Company intelligence / Profile preview

Nala

Singapore, Singaporenala.org ↗

Ownership: Private
Development stage: Commercial

Overview

Nalagenetics offers clinically validated genetic tests tailored to Southeast Asian populations. Their platform provides actionable insights for healthcare providers and patients in areas such as nutrition, cancer risk assessment, drug response (pharmacogenomics), and general wellness. Tests are processed in CLIA-certified/CAP-accredited labs using microarray and qPCR technology. The company has established partnerships with hospitals/clinics to integrate their solutions into routine care.

Modalities: Diagnostic testGenetic test
Industry: Molecular Diagnostics

Partnerships

A*STAR’s Genome Institute of Singapore (GIS)Hospitals/clinics across Southeast Asia integrating their platform into clinical practice

Beyond the preview

Go deeper on Nala.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nala.

Explore the full profile